Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: A phase II trial

Urology

Volumn 57, Issue 1, 2001, Pages 55-59

  Otto, Thomas ^a   Krege, Susanne ^a   Suhr, Julia ^a   Rübben, Herbert ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER SURGERY; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; CYSTECTOMY; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN NEOPLASMS; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0035151884     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00867-0     Document Type: Article

References (33)

1. M-VAC for advanced transitional cell carcinoma of the urothelium
2. Combination therapy with Taxol and carboplatin in advanced transitional cell cancer
3. Cisplatin, gemcitabine and paclitaxel chemotherapy of advanced bladder cancer
4. Second-line chemotherapy with every 2-week gemcitabine and paclitaxel in previously treated patients with transitional cell carcinoma
5. Gemcitabine monotherapy as 2nd-line treatment in cisplatin refractory transitional cell carcinoma
6. The distribution of secondary growths in cancer of the breast
7. Localization of solitary and multiple metastases in stage II non seminomatous testis tumor as basis for a modified staging lymph node dissection in stage I
8. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer
9. Initial chemotherapy for stage II testicular non-seminoma
10. Results of postchemotherapy adjunctive retroperitoneal lymph node dissection in non seminomatous germ cell cancer patients
11. Surgical resection of solitary metastases after chemotherapy in patients with non seminomatous germ cell tumors and elevated serum tumor markers
12. Peritoneal carcinomatosis in nongynecology malignancy; a prospective study of prognostic factors
13. Control of malignant ascites with spironolactone
14. A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma; results and a report on prognostic factors in a Medical Research Council Study
15. Direct diffusion of cisdiamminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitoneal chemotherapy; a comparison with systemic chemotherapy
16. Dosage and its safety on intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer
17. Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer
18. Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)
19. Treatment of malignant ascites
20. A new surgical approach for the treatment of peritoneal metastases in urological carcinomas-a phase II study
21. Outcome after limited posterior surgery for thoracic and lumbar spine metastases
22. Treatment of spinal metastases from kidney cancer by presurgical embolization and resection
23. Gamma knife surgery for cerebral metastases; implications for survival based on 16 years experience
24. Local control after surgical treatment of spinal metastatic disease
25. Prognostic factors in surgery for pulmonary metastases in children
26. The role of surgery excision in the management of relapsed Wilms' tumor patients with pulmonary metastases; a report from the National Wilms' Tumor Study
27. Locally advanced carcinoma of the colon and rectum involving the urinary bladder
28. Extended resection for locally advanced colorectal carcinoma
29. Chirurgische Aspekte bei Lungenmetastasen
30. Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission
31. Major hepatic resection; an update
32. Thoracotomy on the patient with previous malignancy; metastasis or new primary?